News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
316,026 Results
Type
Article (12105)
Company Profile (17)
Press Release (303900)
Multimedia
Podcasts (36)
Webinars (9)
Section
Business (86147)
Career Advice (571)
Deals (20476)
Drug Delivery (45)
Drug Development (42183)
Employer Resources (58)
FDA (8748)
Job Trends (7272)
News (160581)
Policy (16542)
Tag
Academia (826)
Accelerated approval (17)
Adcomms (10)
Allergies (76)
Alliances (19584)
ALS (70)
Alzheimer's disease (793)
Antibody-drug conjugate (ADC) (123)
Approvals (8960)
Artificial intelligence (221)
Autoimmune disease (49)
Automation (13)
Bankruptcy (182)
Best Places to Work (5985)
BIOSECURE Act (7)
Biosimilars (102)
Biotechnology (11)
Bladder cancer (97)
Brain cancer (29)
Breast cancer (328)
Cancer (2384)
Cardiovascular disease (204)
Career advice (511)
Career pathing (14)
CAR-T (100)
CDC (19)
Cell therapy (321)
Cervical cancer (20)
Clinical research (37708)
Collaboration (675)
Compensation (265)
Complete response letters (25)
COVID-19 (1177)
CRISPR (36)
C-suite (297)
Cystic fibrosis (82)
Data (3717)
Decentralized trials (2)
Denatured (10)
Depression (67)
Diabetes (241)
Diagnostics (3170)
Digital health (20)
Diversity (3)
Diversity, equity & inclusion (18)
Drug discovery (87)
Drug pricing (94)
Drug shortages (10)
Duchenne muscular dystrophy (126)
Earnings (44087)
Editorial (32)
Employer branding (3)
Employer resources (51)
Events (42104)
Executive appointments (418)
FDA (10497)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (3)
Frontotemporal dementia (14)
Funding (556)
Gene editing (78)
Generative AI (20)
Gene therapy (272)
GLP-1 (417)
Government (2229)
Grass and pollen (4)
Guidances (336)
Healthcare (8269)
HIV (25)
Huntington's disease (18)
IgA nephropathy (57)
Immunology and inflammation (95)
Immuno-oncology (19)
Indications (51)
Infectious disease (1292)
Inflammatory bowel disease (102)
Inflation Reduction Act (5)
Influenza (56)
Intellectual property (140)
Interviews (67)
IPO (11404)
IRA (29)
Job creations (1577)
Job search strategy (453)
Kidney cancer (9)
Labor market (46)
Layoffs (187)
Leadership (11)
Legal (3085)
Liver cancer (41)
Longevity (2)
Lung cancer (336)
Lymphoma (217)
Machine learning (16)
Management (22)
Manufacturing (342)
MASH (97)
Medical device (6724)
Medtech (6749)
Mergers & acquisitions (9814)
Metabolic disorders (584)
Multiple sclerosis (88)
NASH (10)
Neurodegenerative disease (114)
Neuropsychiatric disorders (34)
Neuroscience (1300)
NextGen: Class of 2025 (2373)
Non-profit (1153)
Now hiring (10)
Obesity (239)
Opinion (108)
Ovarian cancer (98)
Pain (88)
Pancreatic cancer (113)
Parkinson's disease (99)
Partnered (17)
Patents (290)
Patient recruitment (208)
Peanut (28)
People (22582)
Pharmaceutical (9)
Pharmacy benefit managers (22)
Phase I (10476)
Phase II (16114)
Phase III (14208)
Pipeline (2713)
Policy (168)
Postmarket research (1217)
Preclinical (3946)
Press Release (8)
Prostate cancer (124)
Psychedelics (23)
Radiopharmaceuticals (116)
Rare diseases (385)
Real estate (2527)
Recruiting (22)
Regulatory (13646)
Reports (20)
Research institute (740)
Resumes & cover letters (59)
Rett syndrome (20)
RNA editing (3)
RSV (30)
Schizophrenia (61)
Series A (76)
Series B (61)
Service/supplier (3)
Sickle cell disease (40)
Special edition (9)
Spinal muscular atrophy (77)
Sponsored (13)
Startups (1069)
State (1)
Stomach cancer (2)
Supply chain (49)
Tariffs (51)
The Weekly (26)
Vaccines (460)
Venture capital (37)
Weight loss (135)
Women's health (25)
Worklife (7)
Date
Today (53)
Last 7 days (290)
Last 30 days (1303)
Last 365 days (16962)
2025 (16682)
2024 (18758)
2023 (21731)
2022 (27433)
2021 (29349)
2020 (27474)
2019 (20271)
2018 (15395)
2017 (15930)
2016 (13385)
2015 (16760)
2014 (11831)
2013 (8925)
2012 (9971)
2011 (10438)
2010 (9363)
Location
Africa (290)
Alabama (25)
Alaska (2)
Arizona (88)
Arkansas (4)
Asia (20058)
Australia (2656)
California (5844)
Canada (1697)
China (533)
Colorado (206)
Connecticut (231)
Delaware (173)
Europe (46912)
Florida (955)
Georgia (179)
Idaho (15)
Illinois (355)
India (30)
Indiana (333)
Iowa (9)
Japan (220)
Kansas (76)
Kentucky (9)
Louisiana (5)
Maine (47)
Maryland (731)
Massachusetts (3731)
Michigan (123)
Minnesota (275)
Mississippi (3)
Missouri (57)
Montana (5)
Nebraska (11)
Nevada (77)
New Hampshire (43)
New Jersey (1792)
New Mexico (4)
New York (1651)
North Carolina (638)
North Dakota (1)
Northern California (2898)
Ohio (136)
Oklahoma (8)
Oregon (17)
Pennsylvania (1234)
Puerto Rico (8)
Rhode Island (18)
South America (472)
South Carolina (28)
Southern California (2281)
Tennessee (66)
Texas (784)
United States (20235)
Utah (179)
Vermont (1)
Virginia (143)
Washington D.C. (42)
Washington State (490)
West Virginia (2)
Wisconsin (33)
Wyoming (2)
316,026 Results for "european commission ec".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
The European Commission (EC) Approves Bio-Thera Solutions’ BAT2206 (USYMRO®, ustekinumab), a biosimilar referencing Stelara®
August 27, 2025
·
5 min read
Press Releases
European Commission (EC) Approves Henlius and Organon’s BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively
September 19, 2025
·
9 min read
Press Releases
Notice of Orphan Drug Designation for JR-446 for Mucopolysaccharidosis Type IIIB by European Commission (EC)
June 24, 2025
·
5 min read
Press Releases
Incyte Announces European Commission Approval of Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma
December 18, 2025
·
9 min read
Press Releases
Celltrion Announces European Commission Approval of Additional Line Extension for Omlyclo™ 300mg
November 18, 2025
·
4 min read
Press Releases
European Commission Approves Subcutaneous Administration of KEYTRUDA® (pembrolizumab) for All Adult Indications Approved in the European Union
November 19, 2025
·
19 min read
Press Releases
Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®
November 26, 2025
·
6 min read
Press Releases
European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab
November 18, 2025
·
6 min read
Press Releases
Samsung Bioepis Gains European Commission (EC) Approval for Denosumab Biosimilar (OBODENCE™, XBRYK™)
February 17, 2025
·
4 min read
Press Releases
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma
November 19, 2025
·
8 min read
1 of 31,603
Next
